Edition:
United States

Aarti Drugs Ltd (ADRG.NS)

ADRG.NS on National Stock Exchange of India

529.30INR
29 Jul 2016
Change (% chg)

Rs-11.65 (-2.15%)
Prev Close
Rs540.95
Open
Rs530.20
Day's High
Rs543.75
Day's Low
Rs527.00
Volume
6,573
Avg. Vol
14,246
52-wk High
Rs775.50
52-wk Low
Rs431.60

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Aarti Drugs Ltd (AARTIDRUGS-IN) 29 Jul 2016 Thomson Reuters Stock Report 11 25.00
Aarti Drugs Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 15 Jul 2016 Reuters Investment Profile 12 20.00
Wright Investors Service Comprehensive Report for Aarti Drugs Limited 6 Jul 2016 Wright Reports 60 75.00
Aarti Drugs Ltd.: Downgraded to Below Average 26 May 2016 Sadif Analytics Prime 3 10.00
Aarti Drugs Ltd. (AARTIDRUGS) - Financial Analysis Review 17 May 2016 GlobalData 27 300.00
Thomson Reuters Stock Report - Aarti Drugs Ltd (AARTIDRUGS-IN) 10 May 2016 Thomson Reuters Stock Report 11 25.00
Is Aarti Drugs Ltd. Stock Still Attractive? 8 May 2016 Sadif Analytics Prime 12 25.00
 
Name Age Since Current Position

Prakash Patil

68 2014 Executive Chairman of the Board, Chief Executive Officer, Managing Director

Chandrakant Gogri

69 2012 Chairman Emeritus

Vibhav Ranade

2016 Company Secretary & Compliance Officer

Harshit Savla

52 2012 Joint Managing Director, Executive Director

Rashesh Gogri

41 2014 Managing Director, Executive Director